Tattoo inks are among the least regulated consumer products injected into human skin. The labels list brand names and color descriptions, not chemical compositions. The actual contents — organic pigments, metal nanoparticles, carrier solvents, preservatives — are often unknown to the tattooist, the consumer, and sometimes the manufacturer.
A comprehensive knowledge base of tattoo ink chemicals (bioRxiv, 2025) catalogs the molecular inventory and investigates associated toxicities. The scale of the unknown is striking: XRF spectroscopy of adverse-reaction samples identifies allergenic metals — titanium, chromium, manganese, nickel, copper — in almost all cases. Raman spectroscopy reveals both declared pigments (azo compounds, quinacridone) and undeclared ones (carbon black, phthalocyanine). The label and the contents diverge routinely.
The analytical challenge is that tattoo pigments change in the skin. UV exposure, immune response, and laser removal all decompose the original molecules into fragments with unknown toxicity. Femtosecond laser removal of Pigment Green 7, for instance, generates fragments that may have different biological activity than the parent compound. The removal process is not simply extracting ink — it's creating new chemicals in situ.
Metal nanoparticles below 100 nm have unique biological uptake pathways. Their small size enables them to cross biological barriers that larger particles cannot, reaching lymph nodes and potentially systemic circulation. The toxicological profile of a nanoparticle depends not just on its composition but on its size, shape, and surface chemistry — properties that change as the particle ages in tissue.
The gap: millions of people have been injected with substances whose long-term effects are unstudied, whose composition is undisclosed, and whose degradation products are uncharacterized. The ink is in the skin. The chemistry continues.